260 related articles for article (PubMed ID: 1970928)
1. Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association.
Solcia E; Capella C; Fiocca R; Rindi G; Rosai J
Am J Surg Pathol; 1990 Jun; 14(6):503-13. PubMed ID: 1970928
[TBL] [Abstract][Full Text] [Related]
2. Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome.
Lehy T; Cadiot G; Mignon M; Ruszniewski P; Bonfils S
Gut; 1992 Sep; 33(9):1275-9. PubMed ID: 1358767
[TBL] [Abstract][Full Text] [Related]
3. Gastric endocrine cell proliferation and fundic argyrophil carcinoid tumors in patients with the Zollinger-Ellison syndrome.
Cadiot G; Lehy T; Mignon M
Acta Oncol; 1993; 32(2):135-40. PubMed ID: 8323754
[TBL] [Abstract][Full Text] [Related]
4. Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome.
Feurle GE
Gut; 1994 Feb; 35(2):275-7. PubMed ID: 8307483
[TBL] [Abstract][Full Text] [Related]
5. Fundic argyrophil carcinoid tumor in a patient with sporadic-type Zollinger-Ellison syndrome.
Cadiot G; Vissuzaine C; Potet F; Mignon M
Dig Dis Sci; 1995 Jun; 40(6):1275-8. PubMed ID: 7781446
[TBL] [Abstract][Full Text] [Related]
6. The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells.
Maton PN; Lack EE; Collen MJ; Cornelius MJ; David E; Gardner JD; Jensen RT
Gastroenterology; 1990 Oct; 99(4):943-50. PubMed ID: 1697548
[TBL] [Abstract][Full Text] [Related]
7. [Endocrine cell proliferation of the fundic mucosa in men not associated with hypergastrinemic states].
Bordi C; D'Adda T; Azzoni C; Pilato FP
Gastroenterol Clin Biol; 1991; 15(5 ( Pt 2)):51C-58C. PubMed ID: 1680768
[No Abstract] [Full Text] [Related]
8. The antral mucosa as a new site for endocrine tumors in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndromes.
Bordi C; Corleto VD; Azzoni C; Pizzi S; Ferraro G; Gibril F; Delle Fave G; Jensen RT
J Clin Endocrinol Metab; 2001 May; 86(5):2236-42. PubMed ID: 11344233
[TBL] [Abstract][Full Text] [Related]
9. Is the multiple endocrine neoplasia type 1 gene a suppressor for fundic argyrophil tumors in the Zollinger-Ellison syndrome?
Cadiot G; Laurent-Puig P; Thuille B; Lehy T; Mignon M; Olschwang S
Gastroenterology; 1993 Aug; 105(2):579-82. PubMed ID: 8101501
[TBL] [Abstract][Full Text] [Related]
10. Development of gastric argyrophil carcinoid tumors in a case of Zollinger-Ellison syndrome with primary hyperparathyroidism during long-term antisecretory treatment.
Mignon M; Lehy T; Bonnefond A; Ruszniewski P; Labeille D; Bonfils S
Cancer; 1987 Jun; 59(11):1959-62. PubMed ID: 2436742
[TBL] [Abstract][Full Text] [Related]
11. Hypergastrinemia and gastric enterochromaffin-like cells.
Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
[TBL] [Abstract][Full Text] [Related]
12. [Macrocarcinoidosis of the stomach in a MEN 1 patient with Zollinger-Ellison syndrome and hyperparathyroidism].
Padberg BC; Zornig C; Müller-Schwefe C; Klöppel G; Schröder S
Pathologe; 1992 Jul; 13(4):215-20. PubMed ID: 1354867
[No Abstract] [Full Text] [Related]
13. A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors.
Berna MJ; Annibale B; Marignani M; Luong TV; Corleto V; Pace A; Ito T; Liewehr D; Venzon DJ; Delle Fave G; Bordi C; Jensen RT
J Clin Endocrinol Metab; 2008 May; 93(5):1582-91. PubMed ID: 18270260
[TBL] [Abstract][Full Text] [Related]
14. Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids.
Azzoni C; Doglioni C; Viale G; Delle Fave G; De Boni M; Caruana P; Ferraro G; Bordi C
Am J Surg Pathol; 1996 Apr; 20(4):433-41. PubMed ID: 8604810
[TBL] [Abstract][Full Text] [Related]
15. Gastric masses in multiple endocrine neoplasia type I-associated Zollinger-Ellison syndrome.
von Rosenvinge EC; Wank SA; Lim RM
Gastroenterology; 2009 Oct; 137(4):1222, 537. PubMed ID: 19723598
[No Abstract] [Full Text] [Related]
16. Enterochromaffin-like (ECL) cells and their growths: relationships to gastrin, reduced acid secretion and gastritis.
Solcia E; Rindi G; Silini E; Villani L
Baillieres Clin Gastroenterol; 1993 Mar; 7(1):149-65. PubMed ID: 7682874
[TBL] [Abstract][Full Text] [Related]
17. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study.
Rindi G; Luinetti O; Cornaggia M; Capella C; Solcia E
Gastroenterology; 1993 Apr; 104(4):994-1006. PubMed ID: 7681798
[TBL] [Abstract][Full Text] [Related]
18. Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas.
Richards ML; Gauger P; Thompson NW; Giordano TJ
World J Surg; 2004 Jul; 28(7):652-8. PubMed ID: 15383867
[TBL] [Abstract][Full Text] [Related]
19. The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids.
Debelenko LV; Emmert-Buck MR; Zhuang Z; Epshteyn E; Moskaluk CA; Jensen RT; Liotta LA; Lubensky IA
Gastroenterology; 1997 Sep; 113(3):773-81. PubMed ID: 9287968
[TBL] [Abstract][Full Text] [Related]
20. Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia.
Ruszniewski P; Podevin P; Cadiot G; Marmuse JP; Mignon M; Vissuzaine C; Bonfils S; Lehy T
Pancreas; 1993 May; 8(3):295-304. PubMed ID: 8097874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
